The impact of smoking status on radiographic progression in patients with ankylosing spondylitis on anti-tumor necrosis factor treatment

HIGHLIGHTS

• who: Tae-Hwan Kim from the Gazi University, Turkey have published the research: The impact of smoking status on radiographic progression in patients with ankylosing spondylitis on anti-tumor necrosis factor treatment, in the Journal: (JOURNAL)
• what: In the daily clinical practice, the authors assess smoking status predominantly when patients visit the hospital for the first time, when the anti-TNF agent is initiated, and when AS disease activity is assessed for insurance reimbursement via interview or self-report. The difference between the present and previous studies is that the authors focused on the specific . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.